临床试验/CTRI/2025/07/091845

CTRI/2025/07/091845尚未招募不适用

Study of incidence, resistance patterns, efficacy of ceftazidime-avibactam and aztreonam in critically ill patients with carbapenem resistant enterobacterales (CRE) infection in a tertiary care setup- A prospective observational study

BLK MAX SUPERSPECIALITY OSPITAL1 个研究点分布在 1 个国家目标入组 84 人开始时间: 2025年8月8日最近更新: 2025年7月25日

试验速览

阶段: 不适用
状态: 尚未招募
发起方
入组人数: 84
试验地点: 1
主要终点: TO FIND THE INCIDENCE OF CRE INFECTION AND 28 DAY MORTALITY IN ADULT PATIENTS ADMITTED IN MICU

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

study of incidence, resistance patters, efficacy of ceftazidime-avibactam and aztreonam in critically ill patients with carbap[enem resistant enterobacterales infection in tertiary care setup-a prospective observational study

研究设计

研究类型: Observational

入排标准

年龄范围: 18.00 Year(s) 至 99.00 Year(s)（—）
性别: All

入选标准

未提供

排除标准

•PREGNANT PATIENTS PATIENT UNLIKELY TO SURVIVE BEYOND 48 HOUR CANCER DIAGNOSIS IMMUNOSUPPRESSIVE/ANTI CANCER THERAPY.

结局指标

主要结局

TO FIND THE INCIDENCE OF CRE INFECTION AND 28 DAY MORTALITY IN ADULT PATIENTS ADMITTED IN MICU

时间窗: TO FIND THE INCIDENCE OF CRE INFECTION AND 28 DAY MORTALITY IN ADULT PATIENTS ADMITTED IN MICU

次要结局

TO STUDY THE TIME TO MICROBIOLOGICAL AND CLINICAL CURE IN ADULT PATIENTS WITH CRE IN ICU
TO STUDY THE RISK FACTORS, ANTIBIOTIC SUSCEPTIBILITY AND RESISTANCE PATTERN (MIC VALUE AND BREAK POINTS) IN ADULT PATIENTS WITH CRE IN ICU
TO STUDY THE FOLLOWING(synergy between CAZ-AVI+ATM)

研究者

发起方

BLK MAX SUPERSPECIALITY OSPITAL

申办方类型

Private hospital/clinic

责任方

Principal Investigator

主要研究者

priyanka sagar

BLK MAX SUPERSPECIALITY HOSPITAL

研究点 (1)

Loading locations...

相似试验

尚未招募

4 期

Impact of Rapid Diagnostics using a FilmArray Test and Early Targeted Treatment with Ceftazidime-Avibactam for Management of Severe Infections: A Comparative Study Against Standard Care

CTRI/2024/04/066197ADVANCE ID5,900

尚未招募

1 期

Comparing the efficacy of two antibiotic groups for gram negative sepsis in intensive care unit

CTRI/2024/04/065863Trishita Saha80

尚未招募

不适用

Effect of Ceftazidime-Avibactam on Carbapenemase-Producing Klebsiella Pneumoniae

NCT07369518Sohag University100

招募中

2/3 期

Effect of Ceftazidime Avibactam (drug) Versus Meropenem (drug) in Patients of ACLF (Liver Disease).

CTRI/2025/02/080203Institute of Liver and Biliary Sciences150

尚未招募

4 期

Comparing the efficacy of single dose Azithromycin vs multiple dose Cefuroxime in addition to Ceftriaxone to Prevent post-surgery infection in women undergoing cessarean section

CTRI/2024/12/077949All India Institute of Medical Sciences178